Oxybutynin Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablet(IR & ER)

Available Strengths: IR: 5 mg, 10 mg; ER: 5 mg, 10 mg

Reference Brands: Ditropan, Oxybutynin XL(US)

Category: Multiple sclerosis

Oxybutynin IR and ER tablets block overactive bladder symptoms by antagonizing muscarinic receptors, reducing involuntary bladder contractions. Benefits include decreased urgency, frequency, and incontinence episodes, improved bladder control, greater comfort, and enhanced quality of life, supporting long-term management of overactive bladder with flexible dosing options. Oxybutynin tablets is available in Tablet(IR & ER) and strengths such as IR: 5 mg, 10 mg; ER: 5 mg, 10 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Oxybutynin tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Oxybutynin tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Oxybutynin IR and ER tablets, marketed as Ditropan and Ditropan XL, are approved in the US by the FDA and in the EU via EMA for overactive bladder management. Regulatory approval requires a detailed dossier containing clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews clinical and quality data, while the EMA ensures compliance with regional standards.